Collection: Thyroid cancer BRAF
-
Dabrafenib, DABRADX, dabrafenib 75 mg
Regular price ¥1,930.00 CNYRegular priceUnit price / per¥3,500.00 CNYSale price ¥1,930.00 CNYSale -
Dabrafenib is indicated for the treatment of patients with unresectable or metastatic BRAF V600E-mutated melanoma
Regular price ¥1,900.00 CNYRegular priceUnit price / per¥3,500.00 CNYSale price ¥1,900.00 CNYSale -
Dabrafenib mesylate capsules……….75mg
Regular price ¥1,500.00 CNYRegular priceUnit price / per -
DABRAMAKS 75 Generic name: Dabrafenib capsules/Dabrafenib
Regular price ¥2,000.00 CNYRegular priceUnit price / per¥3,000.00 CNYSale price ¥2,000.00 CNYSale -
Sorafenib Soranni SORAFENIB TOSYLATE 200 MG 56 tablets Approval No. 09 L 0700/16 Valid until 27-6-2026
Regular price ¥525.00 CNYRegular priceUnit price / per¥1,000.00 CNYSale price ¥525.00 CNYSale -
Sorafenib 1. Unresectable hepatocellular carcinoma. 2. Advanced renal cell carcinoma. 3. Locally recurrent or metastatic, progressive, differentiated thyroid cancer resistant to radioactive iodine therapy.
Regular price ¥630.00 CNYRegular priceUnit price / per¥900.00 CNYSale price ¥630.00 CNYSale